Table 2. Infectious disease prevalence at enrollment a.
| Test | All women (n=95) | Mycoplasma genitalium | P value | |
|---|---|---|---|---|
|
| ||||
| Positive (n=8) | Negative (n=87) | |||
| Chlamydia | 0.47 | |||
| Positive | 6 (6.3) | 1 (12.5) | 5 (5.8) | |
| Negative | 88 (92.6) | 7 (87.5) | 81 (93.1) | |
| Not done | 1 (1.1) | 0 (0.0) | 1 (1.2) | |
| Gonorrhea | >0.99 | |||
| Positive | 1 (1.1) | 0 (0.0) | 1 (1.2) | |
| Negative | 93 (97.9) | 8 (100.0) | 85 (97.7) | |
| Not done | 1 (1.1) | 0 (0.0) | 1 (1.2) | |
| Bacterial vaginosis | 0.33 | |||
| Positive | 42 (44.2) | 6 (75.0) | 36 (41.4) | |
| Negative | 33 (34.7) | 1 (12.5) | 32 (36.8) | |
| Not done | 12 (12.6) | 1 (12.5) | 11 (12.6) | |
| Indeterminate | 8 (8.4) | 0 (0.0) | 8 (9.2) | |
| Syphilis | >0.99 | |||
| Positive | 1 (1.1) | 0 (0.0) | 1 (1.2) | |
| Negative | 94 (99.0) | 8 (100.0) | 86 (98.9) | |
a
Values are given as number (percentage) or median (interquartile range) unless otherwise indicated.